Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GlaxoSmithKline nabs 'breakthrough' label for Tafinlar in lung cancer
Fierce Pharma
Tuesday, January 14, 2014 - 8:27am
tags:
GSK, Tafinlar, lung cancer, breakthrough therapies
VIVUS collaborates with Aetna on Qsymia
Yahoo/Fly on the Wall
Tuesday, January 14, 2014 - 8:19am
tags:
Vivus, Aetna, Qsymia
Denmark's Novo Nordisk sued in U.S. over generic Prandin
Yahoo/Reuters
Tuesday, January 14, 2014 - 8:18am
tags:
Novo Nordisk, generics, Prandin, diabetes, Caraco
Questcor: Continued Strong Earnings Will Drive It Over $90
Seeking Alpha
Tuesday, January 14, 2014 - 8:16am
tags:
Questcor, earnings
Merck Becomes Latest Pharma to Consider Breakup
TheStreet.com
Tuesday, January 14, 2014 - 8:16am
tags:
Merck, animal health, restructuring
[video] Tesaro: Next big thing in biotech?
CNBC
Tuesday, January 14, 2014 - 8:11am
tags:
Tesaro, rolapitant, chemotherapy-induced nausea and vomiting
Ligand Pharmaceuticals Poised For Full-Year Profit
Investors.com
Tuesday, January 14, 2014 - 8:08am
tags:
Ligand Pharmaceuticals, earnings
AstraZeneca sees 2017 revenue in line with 2013 level
Yahoo/Reuters
Tuesday, January 14, 2014 - 8:07am
tags:
earnings, AstraZeneca
Lilly buys back a migraine therapy from Arteaus Therapeutics
Fierce Biotech
Monday, January 13, 2014 - 5:14pm
tags:
Arteaus Therapeutics, migraines, Eli Lilly
Look for an M&A scramble in 2014, with pharma chasing deals at ever-higher prices
Fierce Pharma
Monday, January 13, 2014 - 5:09pm
tags:
M&A
Cubist rises after saying greater Cubicin sales and acquisitions boosted its 4th-qtr revenue
Yahoo/AP
Monday, January 13, 2014 - 5:08pm
tags:
Cubist, Cubicin, earnings
Pfizer’s Management Changes Are Raising Eyebrows
Wall St Cheat Sheet
Monday, January 13, 2014 - 5:06pm
tags:
Pfizer
Celgene cuts 4Q, 2013 adj. profit outlooks
Yahoo/AP
Monday, January 13, 2014 - 5:05pm
tags:
Celgene, earnings
Cell Therapeutics Regains Rights to Two In-Development Cancer Medicines
Wall St Cheat Sheet
Monday, January 13, 2014 - 5:03pm
tags:
Cell Therapeutics, Novartis, Opaxio, Pixuvri
Novavax:A Biotech Story Set To Double In 2014
Seeking Alpha
Monday, January 13, 2014 - 5:02pm
tags:
Novavax, Abbott Laboratories, Novartis, Baxter International, Virus-like Particles, recombinant protein micelles
Alnylam Snaps Up Merck’s Sirna Therapeutics
Wall St Cheat Sheet
Monday, January 13, 2014 - 2:51pm
tags:
siRNA, M&A, Merck, Alnylam, RNAi
3 Biotechs Generating a Lot Of Buzz
Wall St Cheat Sheet
Monday, January 13, 2014 - 2:47pm
tags:
Celgene, Arrowhead Research, Clovis Oncology, ARC-520, CO-1686, Lucitanib, rucaparib
3 Companies Banking on Regenerative Medicine
Wall St Cheat Sheet
Monday, January 13, 2014 - 2:44pm
tags:
regenerative medicine, Cellular Dynamics, Cytori, Athersys
Merck Rises Most Since 2009 on Seeking Early FDA Approval
Bloomberg
Monday, January 13, 2014 - 2:41pm
tags:
Merck, FDA, melanoma, MK-3475
J.P. Morgan Healthcare Confab Live Blog: Day One
TheStreet.com
Monday, January 13, 2014 - 11:09am
tags:
JPMHC 2014

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.